Instrument Inactif

Communiqués Wound Management Technologies Inc Other OTC

Actions

US98211X1063

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Sanara MedTech : Management Change/Compensation Form 8 K	19/06	PU
Sanara MedTech Inc. Announces First Quarter 2024 Results	13/05	AQ
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates	29/04	AQ
Sanara MedTech Inc. Announces $55 Million Debt Facility	18/04	AQ
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer	05/04	AQ
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results	25/03	AQ
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates	13/03	AQ
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023	22/02	AQ
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides	03/01	AQ
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing	30/11	AQ
Sanara MedTech Inc. Announces Third Quarter 2023 Results	13/11	AQ
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates	30/10/23	AQ
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates	10/10/23	AQ
Sanara MedTech to Participate in Two Upcoming Conferences	12/09/23	AQ
Sanara MedTech : Regulation FD Disclosure - Form 8-K	16/08/23	PU
Sanara MedTech Inc. Announces Second Quarter 2023 Results	14/08/23	AQ
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business	02/08/23	AQ
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates	01/08/23	AQ
SANARA MEDTECH INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	06/06/23	AQ
Sanara MedTech Inc. Announces First Quarter 2023 Results	15/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Wound Management Technologies Inc Other OTC

Actions

US98211X1063

Communiqués

Filtres